Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva M Putz

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Oncoimmunology|May 6, 2015
STAT1-S727 - the license to killEva M Putz, Dagmar Gotthardt, Veronika Sexl
Blood|September 4, 2014
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillanceDagmar Gotthardt, Eva M Putz, Elisabeth Straka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 8, 2024
Boosting the anti-tumor activity of natural killer cells by caripe 8 - A Carapichea ipecacuanha isolated cyclotideJulia List, Jasmin Gattringer, Sophie Huszarek, et al.
Channels (Austin, Tex.)|June 5, 2024
Cell size induced bias of current density in hypertrophic cardiomyocytesElena Lilliu, Benjamin Hackl, Eva Zabrodska, et al.
Oral Oncology|November 29, 2021
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II studyThorsten Fuereder, Christoph Minichsdorfer, Martina Mittlboeck, et al.
Oncoimmunology|March 28, 2017
Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasisEva M Putz, Camille Guillerey, Kevin Kos, et al.
Cancer Immunology Research|October 27, 2017
Interleukin-12 from CD103<sup>+</sup> Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of MetastasisDeepak Mittal, Dipti Vijayan, Eva M Putz, et al.
The Journal of Clinical Investigation|June 6, 2017
NK cell heparanase controls tumor invasion and immune surveillanceEva M Putz, Alyce J Mayfosh, Kevin Kos, et al.
Oncoimmunology|November 22, 2012
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillanceTatsuaki Mizutani, Nina Neugebauer, Eva M Putz, et al.
Nature Communications|August 22, 2020
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR functionBenjamin Salzer, Christina M Schueller, Charlotte U Zajc, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Oncoimmunology|May 6, 2015
STAT1-S727 - the license to killEva M Putz, Dagmar Gotthardt, Veronika Sexl
Blood|September 4, 2014
Loss of STAT3 in murine NK cells enhances NK cell-dependent tumor surveillanceDagmar Gotthardt, Eva M Putz, Elisabeth Straka, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 8, 2024
Boosting the anti-tumor activity of natural killer cells by caripe 8 - A Carapichea ipecacuanha isolated cyclotideJulia List, Jasmin Gattringer, Sophie Huszarek, et al.
Channels (Austin, Tex.)|June 5, 2024
Cell size induced bias of current density in hypertrophic cardiomyocytesElena Lilliu, Benjamin Hackl, Eva Zabrodska, et al.
Oral Oncology|November 29, 2021
Pembrolizumab plus docetaxel for the treatment of recurrent/metastatic head and neck cancer: A prospective phase I/II studyThorsten Fuereder, Christoph Minichsdorfer, Martina Mittlboeck, et al.
Oncoimmunology|March 28, 2017
Targeting cytokine signaling checkpoint CIS activates NK cells to protect from tumor initiation and metastasisEva M Putz, Camille Guillerey, Kevin Kos, et al.
Cancer Immunology Research|October 27, 2017
Interleukin-12 from CD103<sup>+</sup> Batf3-Dependent Dendritic Cells Required for NK-Cell Suppression of MetastasisDeepak Mittal, Dipti Vijayan, Eva M Putz, et al.
The Journal of Clinical Investigation|June 6, 2017
NK cell heparanase controls tumor invasion and immune surveillanceEva M Putz, Alyce J Mayfosh, Kevin Kos, et al.
Oncoimmunology|November 22, 2012
Conditional IFNAR1 ablation reveals distinct requirements of Type I IFN signaling for NK cell maturation and tumor surveillanceTatsuaki Mizutani, Nina Neugebauer, Eva M Putz, et al.
Nature Communications|August 22, 2020
Engineering AvidCARs for combinatorial antigen recognition and reversible control of CAR functionBenjamin Salzer, Christina M Schueller, Charlotte U Zajc, et al.
Pageof 2